New
Capstan Therapeutics
The AI engine Fit Assessment
BetaCapstan Therapeutics develops RNA-based therapies using targeted delivery systems to enhance treatments for oncology, fibrosis, and inflammation-related diseases.
Blurb
Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.
HQ Location
San Diego (United States)
Founded
2021
Employees
51 - 200
Total funding raised
$340.00M
Last Funding Event
Series B, $175.00M, March 20, 2024
Smart insights
- 1Y headcount growth: 19%
- Headcount-to-last-round ratio: 1.1 employees/$M
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.